| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
-0.024 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |